Clinical Trials Directory

Trials / Completed

CompletedNCT01260883

Ketorolac in Postoperative Infants: Pharmacokinetics and Safety

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Seattle Children's Hospital · Academic / Other
Sex
All
Age
2 Months – 18 Months
Healthy volunteers
Not accepted

Summary

Infants handle ketorolac differently than adults. Study of handling of this pain medication given to infants following surgery. Detailed analysis of how the drug is eliminated from age 2 months to 18 months. Compared morphine use in infants who received the drug to the group getting placebo. Safety testing for kidney and liver function, breathing measured by continuous oximetry, and any bleeding issues.

Detailed description

Population kinetic analysis of ketorolac stereo-isomer concentrations after single dose given postoperatively in infants aged 2-18 months. Safety assessments of renal and hepatic function tests by blood tests before and after drug administration, urinalysis pre- and post-drug, continuous oximetry before and for 12 hours after drug. Morphine use between active drug groups and placebo group in the first 24 hours after surgery was assessed as a surrogate analgesic measure in these non-verbal infants. A modified infant pain scale was used to assure consistent pain management.

Conditions

Interventions

TypeNameDescription
DRUGKetorolac Tromethamine 1 mg/kgKetorolac Tromethamine 1 mg/kg infusion over 10 minutes intravenous (IV) infusion. Blood sampling in for up to 12 hours after infusion for analysis of ketorolac concentrations and safety assessments.
DRUGKetorolac Tromethamine 0.5 mg/kgKetorolac Tromethamine 0.5 mg/kg infusion over 10 minutes intravenous (IV) infusion. Blood sampling for up to 12 hours after infusion for analysis of ketorolac concentrations and safety assessments.
DRUGPlaceboDextrose in water (D5W) infusion over 10 minutes intravenous (IV) infusion. Blood sampling for up to 12 hours after infusion for analysis of ketorolac concentrations and safety assessments.

Timeline

Start date
2000-05-01
Primary completion
2008-03-01
Completion
2010-12-01
First posted
2010-12-15
Last updated
2013-06-13
Results posted
2012-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01260883. Inclusion in this directory is not an endorsement.

Ketorolac in Postoperative Infants: Pharmacokinetics and Safety (NCT01260883) · Clinical Trials Directory